Related Experiment Video
Updated: Apr 10, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Dynamic changes in symptom clusters and their influencing factors in oral cancer patients throughout the treatment
Jiarou Zhang1, Yulai Guo1, Xiaoyan Zheng2
1The School of Nursing, Fujian Medical University, Fujian, 350000, China.
Purpose:
This study examines the symptom clusters present in patients with oral cancer and assesses the impact of age, sex, tumor site, and clinical stage as four covariates on their longitudinal trajectories.
Methods:
This study collected data from 108 patients with oral cancer treated with surgery followed by chemoradiotherapy at a single center across six time points: 24 h before surgery, 7 days after surgery, 24 h before discharge, 24 h before initiation of CRT, within 24 h after completion of CRT, and 2 weeks after completion of CRT. PCA was performed on pooled observations from all time points to extract symptom clusters and LME modeled their temporal trajectories. The analysis accounted for age, sex, tumor site, and clinical stage as covariates, incorporating collinearity testing and model diagnostics.
Results:
Five clusters were identified: Oropharyngeal-Systemic Discomfort (OSD), Upper GI-Sleep Disruption (USD), Oral Sensory Abnormality (OSA), Neuro-Constipation (NC), and Emotional-Somatic Reaction (ESR). OSD followed a quadratic (increase-then-decrease) trend, USD initially declined before rising, and OSA increased continuously. Clinical stage was significantly associated with OSD and USD trajectories, whereas age primarily related to OSA. Although change rates were comparable across clusters, higher baseline burdens predicted less improvement in USD and OSA, with a similar trend observed for NC. Diagnostics supported robust fit for OSD, USD, and OSA models, while NC and ESR findings warrant cautious interpretation.
Conclusion:
Combining PCA and LME effectively delineates symptom dynamics in oral cancer. Age and clinical stage serve as key factors, supporting the potential for early high-risk patient identification and personalized supportive care.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Assessment of the Mouth
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Disorders of the Female Reproductive System
